ViewRay cancels plans to raise $52 million through IPO, strikes deal with Houston-based lender

Story excerpt provided by Crain’s Cleveland Business.

Written by Chuck Soder.

ViewRay cancelled its plans to raise $52 million on the stock market, but it now has another source of capital.

The radiation therapy technology company has struck a deal that will allow it to raise up to $50 million in debt financing from CRG, a Houston-based lender that focuses on health care companies.

Click here to read the complete article.

Originally published June 30, 2015.